(Q35982031)

English

The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

Stein RC

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Dowsett M

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Hedley A

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Gazet JC

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Ford HT

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Coombes RC

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

1 October 1990

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

62

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

679-683

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Regulation of estrogen biosynthesis by human adipose cells in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

2 October 2017

Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

2 October 2017

The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

2 October 2017

Potent agonist and antagonist analogues of luliberin containing an azaglycine residue in position 10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

2 October 2017

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

2 October 2017

Aminoglutethimide in treatment of metastatic breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

2 October 2017

4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

11 July 2018

Differential responses of sex steroid target tissues of rats treated with 4-hydroxyandrostenedione

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

11 July 2018

Effect of treatment with aromatase inhibitor 4-hydroxandrostenedione on the nonhuman primate menstrual cycle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

11 July 2018

Plasma Precursors of Estrogen. II. Correlation of the Extent of Conversion of Plasma Androstenedione to Estrone with Age1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

24 September 2018

In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance of the ovary to blockade of aromatization with aminoglutethimide

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine and Therapeutic Effects of Aminoglutethimide in Premenopausal Patients with Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A standardised multicentre procedure for plasma gonadotrophin radioimmunoassay

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic significance and the mechanism of action of the LH-RH agonist ICI 118630 in breast and prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the effect of 4-hydroxy-4-androstene-3,17-dione on aromatase activity in granulosa cells from preovulatory follicles of rats, rabbits, and humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aminoglutethimide in the treatment of premenopausal patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of postmenopausal ovarian steroidogenesis with the luteinizing hormone-releasing hormone agonist goserelin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intratumoral aromatase as a prognostic factor in human breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Menopausal Transition: Analysis of LH, FSH, Estradiol, and Progesterone Concentrations During Menstrual Cycles of Older Women

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1990.356

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35982031&oldid=2198023349"